Specialized Pro-Resolving Mediators
Products for Specialized Pro-Resolving Mediators
- Cat.No. Nom du produit Informations
- GC40971 10(S),17(S)-DiHDHA La 10(S),17(S)-DiHDHA (également connue sous le nom de neuroprotectine D1 lorsqu'elle est produite dans les tissus neuronaux) est un acide gras dihydroxy dérivé du DHA qui présente de puissantes activités protectrices et anti-inflammatoires.
- GC41206 14(S)-HDHA La 14(S)-HDHA (14(S)-HDoHE) est un produit d'oxygénation de l'acide docosahexaénoÏque (DHA).
-
GC41415
15(R)-Lipoxin A4
Lipid-derived lipoxins are produced at the site of vascular and mucosal inflammation where they down-regulate polymorphonuclear leukocyte recruitment and function.
- GC41207 17(R)-HDHA Resolvins are a group of polyhydroxylated metabolites of docosahexaenoic acid (DHA) found in the inflammatory exudates of aspirin-treated experimental animals.
- GC49178 17(R)-Protectin D1 An aspirin-triggered epimer of protectin D1
-
GC41951
17(R)-Resolvin D1
Resolvins are a family of potent lipid mediators derived from both eicosapentaenoic acid and docosahexaenoic acid.
- GC41227 17(R)-Resolvin D1 methyl ester 17(R)-Resolvin D1 (17(R)-RvD1) is an aspirin-triggered epimer of RvD1 that reduces human polymorphonuclear leukocyte transendothelial migration, the earliest event in acute inflammation, with equipotency to RvD1 (EC50 = ~30 nM).
- GC45307 17(R)-Resolvin D3
- GC41952 17(R)-Resolvin D4 17(R)-Resolvin D4 (17(R)-RvD4) is an aspirin-triggered epimer of RvD4 .
- GC41208 17(S)-HDHA 17(S)-HDHA is a primary mono-oxygenation product of docosahexaenoic acid in human whole blood, human leukocytes, and mouse brain.
- GC40975 17(S)-HpDHA 17(S)-HpDHA is a mono-oxygenation product of docosahexaenoic acid in human whole blood, human leukocytes, human glial cells, and mouse brain.
- GC41424 6(S)-Lipoxin A4 The lipoxins are trihydroxy fatty acids containing a 7,9,11,13-conjugated tetraene.
- GC46732 7(S),17(S)-dihydroxy-8(E),10(Z),13(Z),15(E),19(Z)-Docosapentaenoic Acid A metabolite of DPA with antiinflammatory properties
- GC40978 7-epi Maresin 1 7-epi Maresin 1 is the inactive 7(S) epimer of Maresin 1, which contains a 7(R) hydroxyl group.
- GC49590 Docosahexaenoic Acid 1,2,3,4-13C An internal standard for the quantification of DHA
-
GC18552
Lipoxin A4
Un acide gras trihydroxylé contenant un tétraène conjugué.
-
GC18680
Lipoxin A4 methyl ester
Lipoxin A4 methyl ester (LXA4 methyl ester) is a more lipid soluble, prodrug formulation of the transcellular metabolite LXA4.
- GC47569 Lipoxin A4-d5 La lipoxine A4-d5 (LXA4-d5) est la lipoxine A4 marquée au deutérium.
- GC40609 Lipoxin A5 Lipoxin A5 (LXA5) is produced by enzymatic transformation of EPA by leukocytes.
- GC18681 Lipoxin B4 Lipoxin B4 (LXB4) is a positional isomer of LXA4 produced by the metabolism of 15-HETE or 15(S)-HpETE by human leukocytes.
- GC41169 Lipoxin B4 methyl ester Lipoxin B4 (LXB4) methyl ester is a lipid soluble prodrug form of the transcellular metabolite LXB4.
- GC40980 Maresin 2 La marésine 2 est un médiateur anti-inflammatoire et pro-résolution des macrophages humains.
- GC44138 MCTR1 Maresin conjugates in tissue regeneration 1 (MCTR1) is a specialized pro-resolving mediator (SPM) synthesized from docosahexaenoic acid in macrophages at the site of inflammation.
- GC44139 MCTR2 Maresin conjugates in tissue regeneration 2 (MCTR2) is a specialized pro-resolving mediator (SPM) synthesized from docosahexaenoic acid in macrophages at the site of inflammation.
- GC44140 MCTR3 Maresin conjugates in tissue regeneration 3 (MCTR3) is a specialized pro-resolving mediator (SPM) synthesized from docosahexaenoic acid in macrophages.
- GC44579 PCTR1 PCTR1 est un puissant agoniste des monocytes/macrophages, régulant les principaux processus anti-inflammatoires et pro-résolvants lors d'une infection bactérienne.
- GC44580 PCTR2 Protein conjugates in tissue regeneration 2 (PCTR2) is a specialized pro-resolving mediator (SPM) synthesized from docosahexaenoic acid.
- GC44581 PCTR3 Protein conjugates in tissue regeneration 3 (PCTR3) is a specialized pro-resolving mediator (SPM) synthesized from docosahexaenoic acid.
- GC40981 Protectin D1 La protectine D1, la neuroprotectine D1 lorsqu'elle est générée par des cellules neurales, fait partie d'une nouvelle famille de produits bioactifs générés À partir de l'acide docosahexaénoÏque.
- GC49873 Protectin D1 methyl ester An esterified form of protectin D1
- GC48993 Protectin D1-d5 An internal standard for the quantification of protectin D1
- GC48035 RCTR1 A specialized pro-resolving mediator
- GC41230 Resolvin D1 methyl ester L'ester méthylique de la résolvine D1 (ester méthylique RvD1) est l'ester méthylique de la résolvine D1.
- GC48041 Resolvin D1-d5 An internal standard for the quantification of RvD1
- GC41231 Resolvin D2 methyl ester Resolvin D2 (RvD2) is a lipid mediator biosynthesized by the sequential oxygenation of docosahexaenoic acid by 15- and 5-lipoxygenase.
- GC49279 Resolvin D2 n-3 DPA A specialized pro-resolving mediator
- GC48042 Resolvin D2-d5 An internal standard for the quantification of RvD2
- GC41232 Resolvin D3 methyl ester Resolvin D3 methyl ester is a methyl ester version of the free acid that may act as a lipophilic prodrug form that will alter its distribution and pharmacokinetic properties.
-
GC44818
Resolvin D4
Resolvin D4 (RvD4) is a specialized pro-resolving mediator derived from docosahexaenoic acid.
-
GC40982
Resolvin D5
Resolvins are a family of potent lipid mediators derived from both eicosapentaenoic acid and docosahexaenoic acid.
- GC48972 Resolvin E2 A specialized pro-resolving mediator
- GC48045 Resolvin E4 A specialized pro-resolving mediator